Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorder

Postgraduate Medicine

Volumn 124, Issue 5, 2012, Pages 23-32

  Brendan Montano, C ^a   Young, Joel ^b  

^a Director of Research   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult; Attention deficit hyperactivity disorder; Continuity of patient care; Primary care; Transition planning

Indexed keywords

CENTRAL STIMULANT AGENT;

ACADEMIC FAILURE; ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CLINICAL RESEARCH; CRIME; DRIVING ABILITY; HEALTH CARE; HEALTH CARE NEED; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; INTERNAL MEDICINE; MEDICAL EDUCATION; PATIENT COMPLIANCE; PEDIATRICS; PERSONNEL SHORTAGE; PRESCRIPTION; PRIMARY MEDICAL CARE; RESIDENT; SOCIAL PROBLEM; SUBSTANCE ABUSE; TREATMENT PLANNING; VOCATION; CHILD; FEMALE; HEALTH CARE DELIVERY; MALE; ORGANIZATION AND MANAGEMENT; STATISTICS; TRANSITION TO ADULT CARE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; TRANSITION TO ADULT CARE; YOUNG ADULT;

EID: 84873258332     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.09.2591     Document Type: Article

References (86)

1. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(10 suppl):85S-121S.
2. Gibbins C, Weiss M. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep. 2007;9(5):420-426.
3. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67.
4. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. London, England: National Collaborating Centre for Mental Health; 2008.
5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.
6. Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989.
7. Langley K, Fowler T, Ford T, et al. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry. 2010;196(3):235-240.
8. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279-289.
9. Steinhoff KW. Special issues in the diagnosis and treatment of ADHD in adolescents. Postgrad Med. 2008;120(3):60-68.
10. Kessler RC, Adler LA, Barkley R, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442-1451.
11. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192-202.
12. Kent KM, Pelham WE Jr, Molina BS, et al. The academic experience of male high school students with ADHD. J Abnorm Child Psychol. 2011;39(3):451-462.
13. Norwalk K, Norvilitis JM, MacLean MG. ADHD symptomatology and its relationship to factors associated with college adjustment. J Atten Disord. 2009;13(3):251-258.
14. Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord. 2004;7(3):163-173.
15. Minkoff NB. ADHD in managed care: an assessment of the burden of illness and proposed initiatives to improve outcomes. Am J Manag Care. 2009;15(5 suppl):S151-S159.
16. Mao AR, Brams M, Babcock T, Madhoo M. A physician's guide to helping patients with ADHD find success in the workplace. Postgrad Med. 2011;123(5):60-70.
17. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics. 1996;98(6 pt 1):1089-1095.
18. Thompson AL, Molina BS, Pelham W Jr, Gnagy EM. Risky driving in adolescents and young adults with childhood ADHD. J Pediatr Psychol. 2007;32(7):745-759.
19. Eme RF. Attention-deficit/hyperactivity disorder and correctional health care. J Correct Health Care. 2009;15(1):5-18.
20. Grieger L, Hosser D. Attention deficit hyperactivity disorder does not predict criminal recidivism in young adult offenders: results from a prospective study. Int J Law Psychiatry. 2012;35(1):27-34.
21. Fletcher J, Wolfe B. Long-term consequences of childhood ADHD on criminal activities. J Ment Health Policy Econ. 2009;12(3):119-138.
22. Young S, Thome J. ADHD and offenders. World J Biol Psychiatry. 2011;12(suppl 1):124-128.
23. Sankaranarayanan J, Puumala SE, Kratochvil CJ. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003. Curr Med Res Opin. 2006;22(8):1475-1491.
24. Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M. Indication and use of drug products used to treat attention-deficit/ hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood. J Child Adolesc Psychopharmacol. 2007;17(3):328-333.
25. McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194(3):273-277.
26. Gotlieb EM, Gotlieb JS. Helping adolescents with attention-deficit/ hyperactivity disorder transition toward adulthood. Adolesc Med State Art Rev. 2009;20(1):203-222, xi.
27. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115(6): 1734-1746.
28. Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol. 2008;18(5):449-459.
29. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20.
30. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006;45(4):408-414.
31. Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. J Am Board Fam Pract. 2004;17(4):235-239.
32. Cox DJ, Mikami AY, Cox BS, et al. Effect of long-acting OROS methylphenidate on routine driving in young adults with atten-tion-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2008;162(8)793-794.
33. Morley CP. Disparities in ADHD assessment, diagnosis, and treatment. Int J Psychiatry Med. 2010;40(4):383-389.
34. Nutt DJ, Fone K, Asherson P, et al; British Association for Psychop-harmacotherapy. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007;21(1): 10-41.
35. Faraone SV, Spencer TJ, Montano CB, Biederman J. Attention-deficit/ hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med. 2004;164(11):1221-1226.
36. Burke R, Spoerri M, Price A, Cardosi AM, Flanagan P. Survey of primary care pediatricians on the transition and transfer of adolescents to adult health care. Clin Pediatr (Phila). 2008;47(4):347-354.
37. Reiss JG, Gibson RW, Walker LR. Health care transition: youth, family and provider perspectives. Pediatrics. 2005;115(1):112-120.
38. Epstein JN, Langberg JM, Lichtenstein PK, Kolb R, Altaye M, Simon JO. Use of an Internet portal to improve community-based pediatric ADHD care: a cluster randomized trial. Pediatrics. 2011;128(5):e1201-e1208.
39. Sim MG, Hulse G, Khong E. When the child with ADHD grows up. Aust Fam Physician. 2004;33(8):615-618.
40. Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65(suppl 3):18-21.
41. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother. 2005;5(4):525-539.
42. Sansone RA, McDonald S, Prutzman C, Henkaline TC. The comfort level of internists with the prescription of psychotropic medication. Int J Psychiatry Med. 2006;36(1):85-92.
43. ACGME website. Family medicine program requirements. http://www. acgme.org/acWebsite/RRC_120/120_prIndex.asp. Accessed April 29, 2011.
44. ACGME website. Internal medicine program requirements. http:// www.acgme.org/acwebsite/rrc_140/140_prindex.asp. Accessed April 29, 2011.
45. Park MJ, Adams SH, Irwin CE Jr. Health care services and the transition to young adulthood: challenges and opportunities. Acad Pediatr. 2011;11(2):115-122.
46. Patel MS, O'Hare K. Residency training in transition of youth with childhood-onset chronic disease. Pediatrics. 2010;126(suppl 3): S190-S193.
47. Taylor N, Fauset A, Harpin V Young adults with ADHD: an analysis of their service needs on transfer to adult services. Arch Dis Child. 2010;95(7):513-517.
48. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
49. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
50. Lebo S. Prescriptive authority update. Merion matters. http://nurse-practitioners-and-physician-assistants.advanceweb.com/Article/ Prescriptive-Authority-Update.aspx. Accessed April 29, 2011.
51. National Alliance on Mental Illness website. Prescribing privileges for psychologists: an overview. http://www.nami.org/Content/Content-Groups/Policy/Issues_Spotlights/Prescribing_Privileges_for_Psycholo-gists_An_Overview.htm. Accessed April 29, 2011.
52. Krupa C. Psychologists seek prescribing rights in 6 states. http://www. ama-assn.org/amednews/m/2011/03/07/pl20307.htm. Accessed April 29, 2011.
53. Lousiana Psychological Association website. Medical psychologists may prescribe medication. http://www.louisianapsychologist.org/ displaycommon.cfm?an=1&subarticlenbr=6. Accessed April 29, 2011.
54. DuPaul GJ, Weyandt LL, O'Dell SM, Varejao M. College students with ADHD: current status and future directions. J Atten Disord. 2009;13(3):234-250.
55. Nicoteri JA, Arnold EC. The development of health care-seeking behaviors in traditional-age undergraduate college students. J Am Acad Nurse Pract. 2005;17(10):411-415.
56. Baverstock AC, Finlay F. Who manages the care of students with Attention Deficit Hyperactivity Disorder (ADHD) in higher education? Child Care Health Dev. 2003;29(3):163-166.
57. Garnier LM, Arria AM, Caldeira KM, Vincent KB, O'Grady KE, Wish ED. Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry. 2010;71(3):262-269.
58. Burns KA. The top ten reasons to limit prescription of controlled substances in prisons. J Am Acad Psychiatry Law. 2009;37(1):50-52.
59. Mészáros A, Czobor P, Bálint S, Komlósi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol. 2009;12(8):1137-1147.
60. Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. Functional impairment and occupational outcome in adults with ADHD [published online ahead of print July 1, 2011]. J Atten Disord.
61. de Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008;65(12):835-842.
62. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524-540.
63. Public Law 111-148: The Patient Protection and Affordable Care Act. Washington, DC: US Government; March 23, 2010.
64. Geenen SJ, Powers LE, Sells W Understanding the role of health care providers during the transition of adolescents with disabilities and special health care needs. J Adolesc Health. 2003;32(3):225-233.
65. American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110(6 pt 2):1304-1306.
66. Lotstein DS, Ghandour R, Cash A, McGuire E, Strickland B, Newa-check P. Planning for health care transitions: results from the 2005-2006 National Survey of Children With Special Health Care Needs. Pediatrics. 2009;123(1):e145-e152.
67. Towns SJ, van Asperen PP. Diagnosis and management of asthma in adolescents. Clin Respir J. 2009;3(2):69-76.
68. Jurasek L, Ray L, Quigley D. Development and implementation of an adolescent epilepsy transition clinic. J Neurosci Nurs. 2010;42(4):181-189.
69. Pacaud D, Yale JF Exploring a black hole: transition from paediatric to adult care services for youth with diabetes. Paediatr Child Health. 2005;10(1):31-34.
70. Treadwell M, Telfair J, Gibson RW, Johnson S, Osunkwo I. Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research. Am J Hematol. 2011;86(1):116-120.
71. Edwin F, McDonald J. Services for adults with attention-deficit hyperactivity disorder: national survey. Psychiatric Bulletin. 2007;31: 286-288.
72. Prevatt F, Proctor B, Best L, Baker L, Van Walker J, Taylor NW The positive illusory bias: does it explain self-evaluations in college students with ADHD? J Atten Disord. 2012;16(3):235-243.
73. Williamson P, Koro-Ljungberg ME, Bussing R. Analysis of critical incidents and shifting perspectives: transitions in illness careers among adolescents with ADHD. Qual Health Res. 2009;19(3):352-365.
74. Gau SS, Ni HC, Shang CY, et al. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder. Aust N Z J Psychiatry. 2010;44(2):135-143.
75. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry. 2000;39(11):1424-1431.
76. Williams ED, Reimherr FW, Marchant BK, et al. Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate. Ann Clin Psychiatry. 2010;22(2):84-93.
77. Simon NM, Otto MW, Weiss RD, et al; STEP-BD Investigators. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004;24(5):512-520.
78. Verbeeck W, Tuinier S, Bekkering GE. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Adv Ther. 2009;26(2):170-184.
79. Barkley RA. Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39(8):1064-1068.
80. Fava M. Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psychiatry. 2003;64(suppl 14):30-34.
81. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord. 2000;60(1):13-23.
82. Brooks JO, Hoblyn JC. Neurocognitive costs and benefits of psychotropic medications in older adults. J Geriatr Psychiatry Neurol. 2007;20(4):199-214.
83. Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP, Roose SP. Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression. Am J Geriatr Psychiatry. 2010;18(2):128-135.
84. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524-540.
85. Faraone SV, Willey C, Peterson S, Stafford JL, Montano CB. A dynamic patient flow model to identify areas to improve awareness and diagnosis in adults with attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1(2):72-85.
86. American Psychiatric Association website. DSM-5 development: attention deficit/hyperactivity disorder (314.0x). http://www.dsm5.org/ ProposedRevisions/Pages/proposedrevision.aspx?rid=383. Accessed January 31, 2011.